Group 1 - The event "Yuelin Tongxin · Shanhai Gongxing" 2025 Linzhi Economic Development Zone Investment Promotion Conference was held in Guangzhou, Guangdong Province [1] - Four representatives from investment enterprises in Linzhi shared their entrepreneurial stories, highlighting unique products such as "Linzhi Beer" and "Motu Tea" [3] - The event featured a dual venue format with an outdoor section that attracted many citizens, showcasing over 80 specialty products from more than 10 enterprises in Linzhi [3] Group 2 - The event was co-hosted by the People's Government of Linzhi City, Tibet Autonomous Region, and the 11th batch of Guangdong aid team to Tibet, with the Linzhi Economic Development Zone Management Committee as the organizer [5] - Four investment projects were signed during the event, with a total signing amount of 605 million yuan, covering clean energy, green industry, and highland specialty agriculture and animal husbandry [5]

Core Viewpoint - The "Yuelin Tongxin · Shanhai Gongxing" 2025 Linzhi Economic Development Zone investment promotion conference was held in Guangzhou, resulting in four investment projects with a total signed amount of 605 million yuan, focusing on clean energy, green industry, and highland特色 agricultural and animal husbandry industries [1] Group 1: Investment and Economic Development - The Linzhi Economic Development Zone is the only economic development zone in Linzhi City, serving as the core platform for local industrial development and investment attraction [1] - The zone is accelerating the construction of a spatial development pattern characterized by "one axis, two cores, and four bases," with a focus on developing clean energy and highland biological industries as the two leading sectors [1] Group 2: Industry Focus - The development strategy includes the collaborative promotion of four supporting industries: green industry, traditional Chinese medicine, modern services, and commercial logistics, forming a "2+4" modern industrial system [1] - The event featured representatives from four enterprises sharing their entrepreneurial stories in Linzhi, highlighting the local business environment [1] Group 3: Exhibition and Community Engagement - The conference utilized an innovative "main venue + outdoor sub-venue" dual venue model, attracting significant public interest with an outdoor exhibition showcasing over 80 unique products from more than 10 enterprises in Linzhi [1] - Featured products included the "highland ginseng" known as Tibetan Huangjing, unique white meat Ganoderma, and Matsutake mushrooms, emphasizing the region's rich natural resources [1]

西藏自治区药品监督管理局副局长次仁罗布说，2025年，按照产业发展、标准先行的思路，西藏药监局 持续推进《95部颁藏药标准》修订工作，向国家药监局上报第四批"寒水石散"等14个品种质量标准修订 草案，目前共上报80个品种，获批11个品种。顺利完成"第二批藏药标准三年行动计划"中的44个品种标 准研究，已发布"藏黄精"等18个藏药标准，不断完善藏药地方标准体系。 11月25日，西藏自治区人民政府新闻办公室举办发布会，邀请西藏自治区药品监督管理局相关负责人介 绍2025年西藏药品安全及医药产业高质量发展情况。 此外，西藏药监局还持续推进"高效办成一件事"，累计办理审批事项9511件，发放电子证照2700余份， 线上行政许可事项办结率达100%。推进藏药"三结合"证据体系下藏药新药研究，全区在研新药品种13 个，发展势头强劲。出台《藏药材产地加工(趁鲜切制)指导意见》，发布第一批9个藏药材产地加工品 种目录及规程，加快藏药材开发利用。藏医器械规范化管理稳步推进，助推"藏医头部热疗仪"等5个藏 医专用医疗器械上市并进入临床使用，填补了藏医器械领域标准和产品的空白，藏医器械产值达1000余 万元，有效推动藏医药传承创新 ...

Core Points - The Tibet Autonomous Region has successfully entered 1,613 first-class prescription information into the "Chinese Tibetan Medicine Resource Database," laying a solid foundation for the protection of Tibetan medicine resources [1][2] - The Tibet Drug Administration is advancing high-quality development in the industry by revising the "95 Tibetan Medicine Standards" and has submitted quality standard revision drafts for 14 varieties to the National Medical Products Administration [1][2] - A total of 80 varieties have been submitted for approval, with 11 varieties already approved, and 44 varieties of standards research have been completed under the "Second Batch of Tibetan Medicine Standards Three-Year Action Plan" [1][2] - The region is actively promoting the development and utilization of Tibetan medicinal materials, having published the first batch of 9 processing varieties and guidelines [1][2] - The Tibet Drug Administration has also conducted the 2025 Tibetan Medicine Practitioner Qualification Examination, with 1,331 participants, receiving widespread recognition [1][2] - The development of the second phase of the smart drug supervision platform has been completed, enhancing the level of drug regulation and achieving seamless integration with national and regional public service systems [2] - The administration has developed technical standards for Tibetan medical devices, leading to the clinical use of five specialized medical devices, which have received positive feedback from Tibetan medical institutions and patients [2]